X2H30R9
Insertion Femoral Vein, Left to New Technology Group 9 with Intraluminal Device, Bioprosthetic Valve, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | H Insertion |
| Body Part | 3 Femoral Vein, Left |
| Approach | 0 Open |
| Device | R Intraluminal Device, Bioprosthetic Valve |
| Qualifier | 9 New Technology Group 9 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family covers implanting a nonbiological device into the heart or a blood vessel that monitors or supports a physiological function without replacing any tissue itself. A common example is a leadless cardiac pacemaker, a self-contained capsule placed directly inside a heart chamber through a catheter rather than through a surgically implanted pulse generator with wire leads. The device senses the heart's electrical activity and delivers pacing impulses as needed, addressing slow or irregular heart rhythms.
Because the New Technology section exists to track devices recently approved for distinct reimbursement and outcomes monitoring, these procedures are typically newer catheter-based alternatives to long-established open or lead-based techniques. Patients considering them are often candidates who face higher risk from traditional lead placement, such as those with prior infections or difficult venous access.
Anatomy & Axis Detail
Femoral Vein, Left
The left femoral vein serves the same physiologic role as its right-sided counterpart, returning blood from the left lower limb and pelvis toward the inferior vena cava, and it is selected as an insertion site when the right side is unavailable, previously used, or anatomically less favorable on preprocedural imaging. Access is typically obtained percutaneously with ultrasound guidance given the vein's proximity to the femoral artery and nerve. A device inserted at this location generally remains lodged within the venous lumen rather than being advanced centrally, distinguishing this procedure from cases where the left femoral vein merely serves as an entry route to another body part. Left-sided naming in documentation is not interchangeable with the right, since laterality affects both surgical planning and any subsequent imaging or device retrieval.
Approach: Open
Open approach in New Technology denotes access to the target site through a surgical incision that exposes the body part directly to view and instrumentation. It stands apart from percutaneous and endoscopic approaches, which achieve access through small punctures or existing openings rather than a deliberate surgical opening of tissue.
Device / Substance / Technology: Intraluminal Device, Bioprosthetic Valve
This value identifies a bioprosthetic heart valve delivered and seated within an existing vascular or valvular lumen, most familiar as the replacement valve used in transcatheter valve procedures. It is distinguished from mechanical or surgically sutured valve prostheses by its catheter-based, intraluminal placement technique. The value applies to the valve itself rather than to adjunct technologies like leaflet-splitting devices used alongside it.
Qualifier: New Technology Group 9
Group 9 is the seventh-position qualifier used in the New Technology section to mark a device, substance, or technique as belonging to the 2022 annual cohort of new technology add-on codes. It has no clinical meaning of its own beyond that vintage tag, so coders rely on the specific table and body system to know what procedure it applies to. It is distinguished from Group 8 and Group 10 purely by the fiscal year the technology was approved for separate identification.
Coding & Documentation
Coders need the operative note to confirm the specific brand or device named in the New Technology table entry, since these codes are device-specific rather than generic. Documentation should state the approach (typically percutaneous), the target chamber, and confirmation that the device itself performs the monitoring or assistive function rather than serving as a structural replacement. A frequent error is defaulting to the standard Cardiovascular section code for pacemaker or device insertion instead of checking whether the specific model qualifies for a New Technology designation, which can materially change reimbursement. Another common miss is failing to update code selection when a device's New Technology group value changes between annual code set updates.
Commonly Confused With
This is easily confused with standard Insertion procedures coded in the regular Cardiovascular System section, where the distinguishing factor is solely whether the device brand appears in the New Technology reference table for that year. It is also distinct from Replacement, which applies when the device or material takes over the physical role of a body part rather than simply monitoring or assisting it.